Novel EGFR TKI theliatinib: an open label, dose escalation phase I clinical trial (CSCO 2017)

Lin Shen, Li Zhang, Hongyun Zhao, Wenfeng Fang, Jifang Gong

 HMPL-309_Ph1_data_CSCO_2017_thumb

Venue: Chinese Society of Clinical Oncology Annual Meeting in Xiamen, China
Session: Esophageal Cancer
Presenter: Jifang Gong
Date: Thursday, September 28, 2017

Download Presentation (PDF)